Aortic dilatation and gastrointestinal disease: expansion of the hyperinsulinism-polycystic kidney disease phenotype
Journal of the Endocrine Society · 02.11.2026 · 10 (12)
DOI: 10.1210/jendso/bvag243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 21.10.2026. Verfasst von Daphne Yau und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Pediatrics, University of Saskatchewan, Saskatoon S7N 0W8, Canada. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
Congenital hyperinsulinism (HI) with polycystic kidney disease (PKD), or HIPKD, is a recently described syndrome caused by a specific promotor variant in PMM2, a gene otherwise associated with PMM2 congenital disorder of glycosylation.
Objective
To describe the HIPKD clinical phenotype, expanding our understanding and its distinction from the congenital disorder of glycosylation phenotype.
Design
Retrospective multicenter cohort study of individuals with HIPKD identified through an international HI genetic referral center. Patients Ten individuals from 9 families compound heterozygous for the promoter variant c.-167G > T and a pathogenic intragenic variant in PMM2.
Intervention
None. Main Outcome Measures Observed clinical features and outcomes.
Results
Median age of presentation was 5 months (range 0-42). Median age at follow up was 12.7 years (range 5.4-20.1). HI was managed with diazoxide monotherapy (7/10 patients), diazoxide and nifedipine (2/10 patients), and carbohydrate supplementation alone (1/10 patient). PKD age at diagnosis and severity was variable, ranging from antenatal presentation requiring renal transplantation, to incidental detection in mid-childhood. Liver cysts were noted in 6/10 patients (5/6 with normal liver function). Five of 7 patients had systemic hypertension and 3/5 were normotensive on losartan at last follow up. Inflammatory bowel disease (IBD) with gastric antral foveolar hyperplasia occurred in 4/10 patients, and aortic root and/or ascending aortic dilation in 4/7 patients who underwent echocardiography, 3 of whom also had IBD.
Conclusion
HIPKD due to a PMM2 promoter variant is associated with broad, multisystem phenotype, including IBD and aortic dilation. These findings support targeted screening for IBD and cardiovascular surveillance in addition to standard endocrine and renal follow up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Pediatrics, University of Saskatchewan, Saskatoon S7N 0W8, Canada.
- Department of Metabolic Medicine, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
- Centre for Inherited Cardiovascular Diseases, Cardiology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
- Department of Paediatric Endocrinology, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
- Division of Endocrinology, Department of Pediatrics, McMaster University, Hamilton L8S 4L8, Canada.
- Universidad de Chile, Santiago, Chile Pediatric Endocrinology Unit, Luis Calvo Mackenna Children´s Hospital and Clinica Alemana, Santiago 7500539, Chile.
ORCID-Profile: Daphne Yau, Elena Cervi, Clare Gilbert, Stephen Marks, Iona Madden, Detlef Bockenhauer, Stephanie Grunewald, Sarah E Flanagan, Antonia Dastamani
Zitieren
APA
Yau, D., Diaz-Moreno, U., Cervi, E., Shaunak, M., Bassilious, E., Kraus Friedmann, J., Jefferies, C., Gilbert, C., Morgan, K., Townsend, N., Marks, S., Stojanovic, J., Madden, I., Bockenhauer, D., Kiparissi, F., Jones, K., Grunewald, S., Flanagan, S. E., & Dastamani, A. (2026). Aortic dilatation and gastrointestinal disease: expansion of the hyperinsulinism-polycystic kidney disease phenotype. Journal of the Endocrine Society, 10(12). https://doi.org/10.1210/jendso/bvag243
Vancouver
Yau D, Diaz-Moreno U, Cervi E, Shaunak M, Bassilious E, Kraus Friedmann J, et al. Aortic dilatation and gastrointestinal disease: expansion of the hyperinsulinism-polycystic kidney disease phenotype. Journal of the Endocrine Society. 2026;10(12). doi:10.1210/jendso/bvag243
BibTeX
@article{Yau2026,
author = {Yau, Daphne and Diaz-Moreno, Unai and Cervi, Elena and Shaunak, Meera and Bassilious, Ereny and Kraus Friedmann, Jonathan and Jefferies, Craig and Gilbert, Clare and Morgan, Kate and Townsend, Nicola and Marks, Stephen and Stojanovic, Jelena and Madden, Iona and Bockenhauer, Detlef and Kiparissi, Fevronia and Jones, Kelsey and Grunewald, Stephanie and Flanagan, Sarah E and Dastamani, Antonia},
title = {Aortic dilatation and gastrointestinal disease: expansion of the hyperinsulinism-polycystic kidney disease phenotype},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {12},
doi = {10.1210/jendso/bvag243}
}
EUVIMED